Home

Einrichtung Fall Kurzes Leben ioannis hipec Überprüfung Ausfall Aktentasche

Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος

OncoSurgery - Σπηλιώτης Ιωάννης - ΚΟΣΤΟΣ ΩΦΕΛΕΙΑ ΑΠΟ ΤΗΝ ΕΦΑΡΜΟΓΗ ΤΗΣ HIPEC  ΣΤΗΝ ΠΕΡΙΤΟΝΑΪΚΗ ΚΑΚΟΗΘΕΙΑ Ολοκληρώθηκε πριν 1 μήνα η αναλυτική καταγραφή  των δεδομένων μιας 15ετίας και 658 περιστατικών με περιτοναϊκή κακοήθεια,
OncoSurgery - Σπηλιώτης Ιωάννης - ΚΟΣΤΟΣ ΩΦΕΛΕΙΑ ΑΠΟ ΤΗΝ ΕΦΑΡΜΟΓΗ ΤΗΣ HIPEC ΣΤΗΝ ΠΕΡΙΤΟΝΑΪΚΗ ΚΑΚΟΗΘΕΙΑ Ολοκληρώθηκε πριν 1 μήνα η αναλυτική καταγραφή των δεδομένων μιας 15ετίας και 658 περιστατικών με περιτοναϊκή κακοήθεια,

Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος

Overall survival of 101 patients undergoing CRS/HIPEC for peritoneal... |  Download Scientific Diagram
Overall survival of 101 patients undergoing CRS/HIPEC for peritoneal... | Download Scientific Diagram

Complications after CRS and HIPEC | Download Table
Complications after CRS and HIPEC | Download Table

hipec - YouTube
hipec - YouTube

Konstantinos Votanopoulos, MD, PhD, FACS | Atrium Health Wake Forest Baptist
Konstantinos Votanopoulos, MD, PhD, FACS | Atrium Health Wake Forest Baptist

hipec - YouTube
hipec - YouTube

Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal  Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at  Considerable Morbidity and Mortality | Semantic Scholar
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar

Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal  Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at  Considerable Morbidity and Mortality | Semantic Scholar
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar

John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman  Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan  Medical Center | LinkedIn
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn

Operating personnel safety during the administration of Hyperthermic  Intraperitoneal Chemotherapy (HIPEC). | Semantic Scholar
Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). | Semantic Scholar

Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal  Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at  Considerable Morbidity and Mortality | Semantic Scholar
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar

CRS and HIPEC in patients with peritoneal metastasis secondary to  colorectal cancer: The small-bowel PCI score as a predictor of survival
CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival

Survival results in 49 patients after HIPEC (hyperthermic... | Download  Scientific Diagram
Survival results in 49 patients after HIPEC (hyperthermic... | Download Scientific Diagram

Significance of Urinary Tract Involvement in Patients Treated with  Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy ( HIPEC) | Semantic Scholar
Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy ( HIPEC) | Semantic Scholar

Liver metastasectomy-cytoreductive surgery- hyperthermic intraperitoneal  chemotherapy and ileal pouch-anal anastomosis: A case report - ScienceDirect
Liver metastasectomy-cytoreductive surgery- hyperthermic intraperitoneal chemotherapy and ileal pouch-anal anastomosis: A case report - ScienceDirect

John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman  Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan  Medical Center | LinkedIn
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn

Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος

Annals of Surgical Oncology 1/2016 | springermedizin.de
Annals of Surgical Oncology 1/2016 | springermedizin.de

CRS and HIPEC in patients with peritoneal metastasis secondary to  colorectal cancer: The small-bowel PCI score as a predictor of survival
CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival

John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman  Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan  Medical Center | LinkedIn
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn